SPP1 and prostate carcinoma: Aberrant over-expression of the SPP1 protein was reported in several solid tumors including prostate cancer [15], lung cancer [16], gastric cancer [17], breast cancer [18] and hepatocellular [19] and it is down-regulated in colorectal and endometrial carcinomas [20,21].